Fig. 2From: Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovirTrends in estimated marginal mean levels of indicators of insulin resistanceBack to article page